Biblio

Export 1991 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2022
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study., J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
S. Cascini, Agabiti, N., Marino, C., Acampora, A., Balducci, M., Calandrini, E., Davoli, M., and Bargagli, A. Maria, Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study., J Alzheimers Dis, vol. 89, no. 2, pp. 681-693, 2022.
Z. D. Green, Vidoni, E. D., Swerdlow, R. H., Burns, J. M., Morris, J. K., and Honea, R. A., Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 2, pp. 559-571, 2022.
K. Wittfeld, Raman, M. R., Conner, S. C., Aslam, A., Teumer, A., Nauck, M., Hosten, N., Habes, M., DeCarli, C., Vasan, R. S., Beiser, A. S., Himali, J. J., Seshadri, S., Grabe, H. J., and Satizabal, C. L., Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults., J Alzheimers Dis, vol. 88, no. 1, pp. 311-32, 2022.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients., J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients., J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment., J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment., J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
I. Beheshti, Geddert, N., Perron, J., Gupta, V., Albensi, B. C., and Ko, J. Hyun, Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods., J Alzheimers Dis, vol. 89, no. 4, pp. 1493-150, 2022.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study., J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
M. Pejstrup Agger, Carstensen, M. Schultz, Henney, M. Alexander, Hansen, L. Skytte, Baandrup, A. Ohlhues, Nguyen, M., Petersen, P. Michael, Madsen, K. Hougaard, and Kjær, T. Wesenberg, Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light., J Alzheimers Dis, vol. 88, no. 1, pp. 335-344, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner., J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner., J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
P. Agarwal, Holland, T. M., James, B. D., Cherian, L. J., Aggarwal, N. T., Leurgans, S. E., Bennett, D. A., and Schneider, J. A., Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study., J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics., J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
K. Toups, Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Jarrett, M., and Bredesen, D. E., Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project., J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
K. Toups, Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Jarrett, M., and Bredesen, D. E., Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project., J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study., J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions., J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions., J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching., J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials., J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.

Pages